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Neonatal sepsis is a common life threatening 
disease with an incidence of 3.5 to 8 cases per 
1,000 live births; and mortality rate 16 to 30%1, 
causing about 1.6 million deaths annually in 
developing countries2. Early diagnosis and 
treatment of neonatal septicemia may help to 
decrease neonatal mortality. Recently, one of the 
new generation of tests to detect early systemic 
infections measures the up regulation of an Fc 
receptor (Fc gamma R1, or CD64) on neutrophils. 
The Fc receptors on white blood cells are very 
important for effective phagocytosis of bacteria and 
are upregulated during infections3. 
Our aim of the work was to estimate the 
percentage of neutrophils that express CD64 by 
flowcytometry in patients with early onset neonatal 
sepsis and to correlate it with other laboratory 




Background: Neonatal sepsis is a life threatening disease with an incidence 
of 3.5 to 8 cases per 1,000 live births; and mortality rate 16 to 30%. 
Cytokines, produced by monocytes, macrophages, and endothelial cells in 
response to infectious stimuli are important proinflammatory mediators in 
the early phases of the sepsis syndrome. Elevated serum levels of 
interleukin-6 (IL-6) had been found in both neonatal and adult sepsis. 
However, for neonatal sepsis, little is known about a group of molecules 
playing a central role in the innate immune system. Among them is the 
neutrophil CD64 which is expressed on neutrophil surface in many 
inflammatory conditions.  
Objective: To study the neutrophil CD64 expression in neonates with early 
onset sepsis and its relation to other laboratory markers as IL6, CRP, total 
leucocytic count and platelet count.  
Methods: This study comprised 30 neonates with a gestational age of 28 to 
40 weeks with a picture of early onset neonatal sepsis within 48 hours of life 
admitted to neonatal care unit, Suzan Mubarak Hospital, El-Minia 
University, Egypt during the period from February, 2008 to January, 2009
and 20 healthy neonates age and sex matched as a control group. Neutrophil 
surface expression of CD64 was quantified with flow cytometry. We 
measured plasma IL6, C-reactive protein, complete blood count and blood 
culture. 
Results: Neutrophil CD64 expression was increased significantly in 
neonates with neonatal sepsis than controls (p=0.001). Cases with history of 
premature rupture of membranes (PROM) ≥48 hours, with positive blood 
culture or poor outcome had the highest levels of neutrophil CD64
expression (528±50.7, 558±58.4 and 560.9±43.9 relative fluorescence units 
(RFU) respectively). A significant positive correlation was found between 
CD64 levels and the levels of IL6 (r=0.71, p=0.001),C-reactive protein 
(r=0.74, p=0.001) and total leucocytic count (r=0.76 ,p=0.01) and negative 
correlation with gestational age (r=-0.92, p=0.001) and body weight (r=-
0.92, p=0.006), but there was no correlation between it and platelet count 
(r=-0.32, p=0.08).  
Conclusion: Neutrophil CD64 expression is increased in neonates with 
early-onset neonatal sepsis and correlated well with other laboratory 
markers of sepsis. 
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METHODS 
This study comprised 30 neonates, with a 
gestational age of 28 to 40 weeks, admitted to the 
neonatal unit, Suzan Mubarak Hospital, El-Minia 
University, Egypt, with a picture of early-onset 
neonatal sepsis, within 48 hours after birth. All 
patients either fulfilled the following inclusion 
criteria: 1) at least 1 risk factor for infection 
(rupture of membranes ≥24 hours, maternal body 
temperature of ≥38°C, chorioamnionitis, maternal 
colonization with group B streptococci, or preterm 
delivery); 2) signs of respiratory or circulatory 
dysfunction (tachypnea >60 bpm, recurrent apnea 
>20 seconds, tachycardia >160 bpm, or bradycardia 
<100 bpm); 3) at least 1 of the following symptoms: 
feeding intolerance, lethargy, irritability, 
temperature instability, or jaundice and (4) blood 
culture positive or at least two of the following 
criteria were met: C-reactive protein (CRP) > 10 
mg/l within 48 h after onset of clinically suspected 
sepsis, pneumonia diagnosed by X ray, by 
microscopic or cultural evidence in tracheal 
aspirate, proportion of immature (bands and less 
mature forms) to total neutrophils of >0.2 
documented in any complete blood count (CBC) 
within 48 hours after clinically suspected sepsis. 
Infants who were more than 48 hours old at 
onset of suspected sepsis, infants who were 
unstable and ventilated with respiratory and/or 
circulatory failure, and infants with neonatal 
asphyxia (Apgar score <7 at 5 minutes) or those 
with congenital malformations were excluded from 
this study. 
Complete blood count with differential count 
determined by automated cell counter sysmex k-
800 (TAO Medical Incorporation, Japan, CRP 
using CRP-Turbi Latex quantitative turbidmetric 
test using kits supplied by SPINEACT,S.T., Spain , 
IL-6 using IL-6 ELISA TEST based on the 
principle of a solid phase enzyme linked 
immunoassay using Enzyme-linked immunosorbent 
assay kits (Quantikine, R&D systems, Minneapolis, 
MN) were used and neutrophil CD64 expression by 
(flowcytometry) was performed. Parental informed 
consent was obtained for every neonate before 
admission to the study. The protocol was approved 
by El-Minia Faculty of Medicine.  
 
Blood samples: From each neonate with suspected 
infection, a blood sample of 1000 µL to 1500 µL 
was drawn by venipuncture for CD64 and IL-6 
determinations, between 0 and 48 hours of life 
before the first doses of antimicrobials. Each blood 
sample was placed into a pyrogen-free tube 
containing citrate phosphate dextrose (Baxter 
Health Care Ltd, Norfolk, England; 0.14 mL/mL 
blood) and cooled immediately to 0°C in an ice-
water bath to minimize neutrophil activation ex 
vivo. 
 
Blood culture: After skin preparation with 70 % 
alcohol, between 1.0 and 2.0 ml of blood was 
obtained and inoculated into Bactec Peds Plus/F 
(Becton Dickinson and Company, Sparks, MD) 
culture vials under sterile conditions. All positive 
vials were Gram-stained and subcultured for 
organism identification on sheep's blood, chocolate, 
and MacConkey agars.   
 
Determination of CD64 expression by flow 
cytometry: We used monoclonal anti-human CD64 
(Fc gamma R I)-fluorescein (Quantikine, R&D 
systems, Minneapolis, MN). Whole blood was 
collected in evacuated tubes containing EDTA or 
heparin as an anticoagulant. Contaminating serum 
components were removed by washing the cells 
three times in an isotonic phosphate buffer 
(supplemented with 0.5% BSA) by centrifugation at 
500×g for 5 minutes. Fifty microliters of packed 
cells were transferred to a 5 ml tube for staining 
with the monoclonal antibody.  
 
Determination of IL-6: Plasma was separated by 
centrifugation and then stored in aliquots at 70°C 
until analysis. IL-6 enzyme-linked immunosorbent 
assay kit (Quantikine, R&D systems, Minneapolis, 
MN) the detection limit of the assay, as indicated by 
the manufacturer, was 10 pg/mL . All samples were 
run in duplicate.  
 
CRP determination: Plasma CRP concentrations 
were measured immunoturbidimetrically (detection 
limit: 5 mg/L). Any levels greater than 10 mg/L 
were defined as abnormal.  
 
Statistical analysis: 
Values are given as means ± SD, range, or as the 
number of subjects and proportions. The Student t 
test was used for group comparisons of normally 
distributed variables, and the Mann-Whitney U test 
and Wilcoxon signed-rank test were used for 
comparisons of variables with skewed distribution. 
The χ2 test was used to compare proportions. 
Correlation coefficients were used to describe 
associations between variables, and multiple 
regression analysis was used to detect any 
relationships between the variables. P < 0.05 was 
considered significant. Analyses were performed 
using the SPSS software package (SPSS  V 8.0 for 
Windows).  
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RESULTS 
Demographic data of the study group were 
presented in table (1). Patients and controls were 
comparable with respect to mean gestational age, 
sex or birth weight. PROM was significantly more 
common in patients group.  
Significant differences were observed in some 
laboratory data. The platelet count was significantly 
lower (p=0.001) and WBCs (p=0.01) and CRP 
were significantly higher (p=0.001) in patients. 
Levels of both CD64 and IL6 were significantly 
higher in cases than controls (p=0.001). Five 
patients were blood-culture positive: 2 for group B 
streptococci, 1 for Streptococcus agalactiae, 1 for 
Escherichia coli, and 1 for Staphylococcus aureus. 
Eleven cases (36.7%) died within the first week of 
this study; two of them were blood culture positive 
(one for Streptococcus agalactiae and the other for 
group B streptococci). (Table 2) 
Significant positive correlations were found 
between CD64 and CRP, IL6 and total leucocytic 
count of patients. Significant negative correlations 
were present between CD64 and platelet count, age 
and weight of patients. PROM for 48 hours or more 
was associated with significant higher levels of 
CD64 and the same was seen in patients who died 
within the first week of life compared to patients 
who survived beyond the first week of life (p=0.04 
&p=0.005). No statistical significant difference in 
CD64 values was found between in patients with 
positive blood culture and those with negative 
blood culture (p=0.08). (Table 4)  
Similarly significant positive correlations were 
found for IL6 level and total leucocytic count as 
well as CRP levels in patients group. A significant 
negative correlation was present between IL6 and 
age, weight and platelet count in patients. A 
significant higher level of IL6 was present in cases 
with positive blood culture (p=0.03). No 
statistically significant difference was present in 


































0(0%) 23(76.6 %) ≥48 hours 
3(15%) 7( 23.3 %  ) ≥24hours 
0.01* 
17(85%) 0 ≤24 hours 
PROM 
 
* Significant, ** Highly significant, PROM: premature rupture of membranes 
 
 
Table 2. Laboratory data of patients and controls. 





















































* Significant, ** Highly significant, RFU= Relative Fluorescence Units 
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Table 3. The relation of CD64 to other studied 
parameters of patients. 
Table 4. The relation of IL6 to other studied 




0.001** -0.92 Age (weeks) 
0.01* -0.91 Weight (grams) 
0.008** -0.70 Platelets (×10³/µl)   
0.01* 0.76 Total WBCs (×10³/µl) 




0.001** -0.68 Age (weeks) 
0.001** -0.71 Weight (grams) 
0.001** 0.65 Total WBCs (×10³/µl) 
0.02* -0.69 Platelets (×10³/µl) 
0.001** 0.63 CRP (mg/l)  





Table 5. Relation of CD64 and IL6 to PROM, blood culture and outcome in neonates with sepsis. 
PROM Blood culture Outcome  
≥ 48 hours ≤ 48hours positive negative survived died 
Range 450-610 450-500 460-610 450-590 450-580 480-610 
Mean ± SD 528.6±50.7 465 ±48.1 558±58.4 522±48.1 508.9±45.07 560.9±43.9 
CD64  
(RFU) 
P-value 0.04* 0.08 0.005** 
Range 8-280 8-195 120-280 8-250 8-240 128.05±59.5 
Mean ± SD 142.9±68.9 125 ±59.3 202±59.3 125 ±59.3 10-280 168.6±76.9 
IL6  
(pg/ml) 
P-value 0.9 0.03* 0.1 











































Figure 1. Comparison between patients and controls as regards CD64, IL6 and CRP levels. 
 
















r=0.70                                            p=0.001** 




There is a clear need for improved indicators of 
neonatal sepsis to increase the sensitivity and 
specificity of both diagnosis and therapeutic 
monitoring. One of the effects of inflammatory 
cytokines on the innate immune response is the 
rapid up-regulation of CD64 expression on the 
neutrophil membrane. During the last years, several 
clinical studies, have demonstrated that levels of 
proinflammatory cytokines, such as TNF-α, IL-1ß, 
IL-6, and IL-8 are elevated in cord blood of 
neonates with sepsis4-8. 
Davis and Bigelow9, Nuutila and coworkers10 
and Rudensky  and coworkers11 reported that 
neutrophil CD64 expression is an improved 
diagnostic indicator of infection/sepsis. The results 
of our study are in line with this as we found 
significantly elevated levels of CD64 in septic 
neonates when compared to healthy controls. These 
findings are also in agreement with other studies12-14 
which reported the same results in neonates with 
early onset sepsis. Another study reported similar 
results in very low birth weight neonates with late 
onset neonatal sepsis15. Among the various 
cytokines, many studies16-18 besides ours reported 
the utility of IL-6 as an early marker of neonatal 
sepsis. 
In this study cases with high risk factors for 
sepsis such as those with PROM ≥48 hours and/or 
positive blood culture, or those who died during the 
first week of life had significantly higher levels of 
CD64 than cases with PROM ≤48 hours, negative 
blood culture or those who survived beyond the 
first week. These findings may reflect the reliability 
of this test as a marker of the severity of cases with 
sepsis and are in concordance with other studies19,20. 
In this study, both CD64 and IL-6 correlated 
positively with CRP levels and total leucocytic 
count which are laboratory markers of neonatal 
sepsis pointing to their usefulness as additional 
markers of sepsis. This is in agreement with 
previous studies19,26-28. 
Thrombocytopenia is one of the most common 
complications of neonatal sepsis21,22 and is 
considered one of the hematological parameters of 
severity of neonatal sepsis23. The finding in the 
present study of a significant negative correlation 
between both CD64 and IL-6 and platelet count 
indicates that both CD64 and IL-6 can be 
considered too as parameters of the severity of 
sepsis. 
No significant difference was noticed between 
patients and controls with respect to the results of 
blood culture in this study. This may be due to the 
small sample size and that only five cases (18%) 
had positive blood cultures. Positive blood cultures 
are reported to be positive only in 13 to 20 % of 
cases suspected of neonatal sepsis24,25. Vineet et al3 
reported that CD64 index had the highest area 
under the curve of all hematological variables, with 
a higher sensitivity and specificity for blood culture 
positive cases. 
The significant negative correlation between 
IL-6 level and both of age and weight in this study 
indicates that sepsis is more severe with younger 
age and lower weight resulting in higher levels of 
these inflammatory cytokines and this is in 
agreement with many studies29,30. 
It is concluded that neutrophil CD64 expression 
is increased in neonates with early-onset neonatal 
sepsis and correlated well with other laboratory 
markers of sepsis as well as outcome of cases. 
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